BJS open r-FISABIO. Repositorio Institucional de Producción Científica instname STARSurg Collaborative and EuroSurg Collaborative 2022, ' Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery ', BJS Open, vol. 6, no. 1, zrab150 . https://doi.org/10.1093/bjsopen/zrab150 BJS open, 6(1):zrab150. John Wiley & Sons Ltd. BJS OPEN Ahmed, W, Bhatia, S, Mclean, K, Khaw, R A, Baker, D E A, Kamarajah, S K, Bell, S, Nepogodiev, D, Harrison, E M & Glasbey, J C 2022, ' Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery ', BJS Open . https://doi.org/10.1093/bjsopen/zrab150 BJS Open, 6 BJS Open, 6(1):zrab150. John Wiley & Sons Inc. BJS Open, 6, 1 BJS open, 6(1):zrab150. BMJ PUBLISHING GROUP STARSurg Collaborative and EuroSurg Collaborative, Kjaer, M D, Unbehaun, K P & Mark-Christensen, A 2022, ' Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery ', BJS open, vol. 6, no. 1, zrab150 . https://doi.org/10.1093/bjsopen/zrab150 BJS Open r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe BJS Open, 6(1). OXFORD UNIV PRESS r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
British journal of surgery, 107(5), 552-559. John Wiley and Sons Ltd EuroSurg Collaborative 2020, ' Safety of hospital discharge before return of bowel function after elective colorectal surgery ', British Journal of Surgery, vol. 107, no. 5, pp. 552-559 . https://doi.org/10.1002/bjs.11422 British Journal of Surgery, 107(5), 552-559. WILEY
NEW ENGLAND JOURNAL OF MEDICINE r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA instname New England Journal of Medicine, 380(24), 2295-2306. MASSACHUSETTS MEDICAL SOC
Lancet Diabetes & Endocrinology r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau instname The Lancet Diabetes & Endocrinology Volume 7 Issue 8 Ray, K K, Colhoun, H M, Szarek, M, Baccara-Dinet, M, Bhatt, D L, Bittner, V A, Budaj, A J, Diaz, R, Goodman, S G, Hanotin, C, Harrington, R A, Jukema, J W, Loizeau, V, Lopes, R D, Moryusef, A, Murin, J, Pordy, R, Ristic, A D, Roe, M T, Tuñón, J, White, H D, Zeiher, A M, Schwartz, G G, Steg, P G & ODYSSEY OUTCOMES Committees and Investigators 2019, ' Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes : a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial ', The Lancet Diabetes and Endocrinology, vol. 7, no. 8, pp. 618-628 . https://doi.org/10.1016/S2213-8587(19)30158-5 Ray, K K, Colhoun, H M, Szarek, M, Baccara-Dinet, M, Bhatt, D L, Bittner, V A, Budaj, A J, Diaz, R, Goodman, S G, Hanotin, C, Harrington, R A, Jukema, J W, Loizeau, V, Lopes, R D, Moryusef, A, Murin, J, Pordy, R, Ristic, A D, Roe, M T, Tuñón, J, White, H D, Zeiher, A M, Schwartz, G G, Steg, P G & ODYSSEY OUTCOMES Committees and Investigators 2019, ' Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes : a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial ', The Lancet Diabetes & Endocrinology, vol. 7, no. 8, pp. 618-628 . https://doi.org/10.1016/S2213-8587(19)30158-5 Lancet diabetes & endocrinology ODYSSEY OUTCOMES Committees and Investigators 2019, ' Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes : a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial ', The Lancet Diabetes and Endocrinology, vol. 7, no. 8, pp. 618-628 . https://doi.org/10.1016/S2213-8587(19)30158-5 Ray, K K, Colhoun, H M, Szarek, M, Baccara-Dinet, M, Bhatt, D L, Bittner, V A, Budaj, A J, Diaz, R, Goodman, S G, Hanotin, C, Harrington, R A, Jukema, J W, Loizeau, V, Lopes, R D, Moryusef, A, Murin, J, Pordy, R, Ristic, A D, Roe, M T, Tunon, J, White, H D, Zeiher, A M, Schwartz, G S, Steg, P G, Schwartz, G G, Steg, P G, ODYSSEY OUTCOMES Committees and Investigators, Clemmensen, P, Gislason, G, Nielsen, P K, Davidsen, F, Andersen, D, Jeppesen, J & Videbæk, L 2019, ' Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial ', The Lancet Diabetes & Endocrinology, vol. 7, no. 8, pp. 618-628 . https://doi.org/10.1016/S2213-8587(19)30158-5 r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA Lancet Diabetes and Endocrinology, 7(8), 618-628. ELSEVIER SCIENCE INC